SCHEMBL29528601

SCHEMBL29528601

Cc1cc(SC(F)(F)F)ccc1Br

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.47
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
PTPRZ1 P23471 3/20 0.37
PTPN1 P18031 2/20 0.37
KCNH2 Q12809 1/20 0.37
LMNA P02545 3/20 0.35
MAPT P10636 3/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
KCNK2 O95069 3/20 0.34
KCNK10 P57789 3/20 0.34
TP53 P04637 1/20 0.34
GAA P10253 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
CHRNA1 P02708 1/20 0.32
CHRNG P07510 1/20 0.32
CHRNB1 P11230 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21225496 1.00 SMN1; SMN2 (0.47) SMN1; SMN2ALDH1A1KDM4ETDP1PTPRZ1
SCHEMBL12828098 0.81 SMN1; SMN2 (0.51) SMN1; SMN2ALDH1A1KDM4ETDP1PTPRZ1
SCHEMBL4157946 0.80 ALDH1A1 (0.52) SMN1; SMN2ALDH1A1KDM4ETDP1PTPRZ1
SCHEMBL16667141 0.78 KCNK2 (0.43) SMN1; SMN2ALDH1A1KDM4ETDP1PTPRZ1
SCHEMBL30410247 0.78 KCNK2 (0.43) SMN1; SMN2ALDH1A1KDM4ETDP1PTPRZ1
SCHEMBL16707555 0.78 SMN1; SMN2 (0.49) SMN1; SMN2ALDH1A1KDM4ETDP1PTPRZ1
SCHEMBL900729 0.78 SMN1; SMN2 (0.49) SMN1; SMN2ALDH1A1KDM4ETDP1PTPRZ1
SCHEMBL10595472 0.76 ALDH1A1 (0.40) SMN1; SMN2ALDH1A1LMNAMAPTTSHR
SCHEMBL10341619 0.76 ALDH1A1 (0.40) SMN1; SMN2ALDH1A1TDP1LMNAMAPT
SCHEMBL24616823 0.76 KDM4E (0.52) SMN1; SMN2ALDH1A1KDM4ETDP1PTPRZ1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025043191-A1 PRC2 INHIBITORS FOR USE IN TREATING SICKLE CELL DISEASE ORIC PHARMACEUTICALS, INC. (US) 2025-02-27 WO disclosed
CN-112004816-B PRC2 inhibitors 米拉蒂医疗股份有限公司 2024-01-05 CN disclosed
WO-2023049723-A1 PRC2 INHIBITORS FOR USE IN TREATING BLOOD DISORDERS ORIC PHARMACEUTICALS, INC. (US) 2023-03-30 WO disclosed
CN-114269748-A Imidazo [1,2-c ] pyrimidine derivatives as PRC2 inhibitors for the treatment of cancer 米拉蒂医疗股份有限公司 2022-04-01 CN disclosed